Sage Journals: Discover world-class research

Abstract

Background

Chronic kidney disease (CKD) is a major disease that endangers public health around the world. The urinary toxins produced in the disease can induce intestinal barrier damage and systemic inflammation, which further aggravates the disease and creates a vicious circle. Therefore, this work carried out cell-level research to determine the ability of Guben Xiezhuo colon dialysis recipe, an herbal compound used to treat CKD under the guidance of traditional Chinese medicine, for colon dialysis to repair the intestinal barrier and to interfere with the entire process.

Methods

T84 cells were divided into six groups according to the level of urinary toxin content and the different drugs added: (1) control group; (2) low-dose urea model group; (3) high-dose urea model group; (4) Nrf2 activator group; (5) NF-κB inhibitor group; (6) Guben Xiezhuo recipe-containing serum group. The immunofluorescence technique was used to analyze the expression characteristics of intestinal epithelial tight junction protein occludin in intestinal epithelial cells in the intestinal barrier injury model. Western blot technology was used to analyze the expression of ZO-1 and claudin-1 in intestinal epithelial cells in the intestinal barrier injury model. RT-PCR technology was used to analyze the expression changes of Keap-1, Nrf2, ROS, and NF-κB mRNA in intestinal epithelial cells. ELISA was used to analyze the content of inflammatory signal hypersensitive C-reactive protein and interleukin-6 (IL-6) in cell culture fluid.

Results

The results of immunofluorescence analysis and Western blot analysis demonstrated the ability of urinary toxins produced by CKD to destroy the intestinal barrier. The results of RT-PCR analysis explained the mechanism of urinary toxins destroying the intestinal barrier at the molecular level. The results of ELISA analysis indicate that the intestinal barrier damage will further induce systemic inflammation. Through the comparison of the above analysis results in the six groups, it can be shown that Guben Xiezhuo colon dialysis recipe has an excellent therapeutic effect on intestinal epithelial injury.

Conclusion

Through the detection and comparison of the contents of intestinal barrier-related proteins and inflammatory signal factors in each group, it is proven that the Guben Xiezhuo colon dialysis recipe has an excellent therapeutic effect on the repair of intestinal barrier damage and further inhibits the deterioration of CKD, which also provides an optional auxiliary strategy.

Keywords

CKD Guben Xiezhuo recipe inflammation

Get full access to this article

View all access options for this article.

References

Chen

Fang

Orlando

R. C.

Shaheen

Chen

X. L.

(2013). NFkb and Nrf2 in esophageal epithelial barrier function. Tissue Barriers, 1(5), e27463. https://doi.org/10.4161/tisb.27463

Chen

Xue

Zheng

Liu

Chen

, et al. (2018). MiR-429 regulated by endothelial monocyte activating polypeptide-II (EMAP-II) influences blood-tumor barrier permeability by inhibiting the expressions of ZO-1, occludin and claudin-5. Frontiers in Molecular Neuroscience, 11, 35. https://doi.org/10.3389/fnmol.2018.00035

Cuadrado

Rojo

A. I.

Wells

Hayes

J. D.

Cousin

S. P.

Rumsey

W. L.

, et al. (2019). Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nature Reviews Drug Discovery, 18(4), 295–317. https://doi.org/10.1038/s41573-018-0008-x

Glorieux

Gryp

Perna

(2020). Gut-derived metabolites and their role in immune dysfunction in chronic kidney disease. Toxins (Basel), 12(4), 24. https://doi.org/10.3390/toxins12040245

Huang

Zhan

Cao

Lyu

Guo

, et al. (2016). Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy, 12(6), 999–1014. https://doi.org/10.1080/15548627.2016.1166318

Lee

J. W.

Lee

S. M.

Chun

J. P.

Seo

S. K.

, et al. (2020). Novel histone deacetylase 6 inhibitor CKD-506 inhibits NF-κB signaling in intestinal epithelial cells and macrophages and ameliorates acute and chronic murine colitis. Inflammatory Bowel Diseases, 26(6), 852–862. https://doi.org/10.1093/ibd/izz317

X. F.

Zhang

X. J.

Zhang

Wang

L. N.

Y. R.

Zhang

, et al. (2018). Ulinastatin protects brain against cerebral ischemia/reperfusion injury through inhibiting MMP-9 and alleviating loss of ZO-1 and occludin proteins in mice. Experimental Neurology, 302, 68–74. https://doi.org/10.1016/j.expneurol.2017.12.016

Marchiando

A. M.

Shen

Graham

W. V.

Weber

C. R.

Schwarz

B. T.

Austin

J. R.

, et al. (2010). Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. Journal of Cell Biology, 189(1), 111–126. https://doi.org/10.1083/jcb.200902153

Meijers

B. K.

Evenepoel

(2011). The gut-kidney axis: Indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrology Dialysis Transplantation, 26(3), 759–761. https://doi.org/10.1093/ndt/gfq818

10.

Mitsuishi

Motohashi

Yamamoto

(2012). The Keap1-Nrf2 system in cancers: Stress response and anabolic metabolism. Frontiers in Oncology, 2, 200. https://doi.org/10.3389/fonc.2012.00200

11.

Pahl

M. V.

Vaziri

N. D.

(2015). The chronic kidney disease – colonic axis. Seminars in Dialysis, 28(5), 459–463. https://doi.org/10.1111/sdi.12381

12.

Panieri

Buha

Telkoparan-Akillilar

Cevik

Kouretas

Veskoukis

, et al. (2020). Potential applications of NRF2 modulators in cancer therapy. Antioxidants (Basel), 9(3), 193. https://doi.org/10.3390/antiox9030193

13.

Rao

N. A.

McCalman

M. T.

Moulos

Francoijs

K. J.

Chatziioannou

Kolisis

F. N.

, et al. (2011). Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Research, 21(9), 1404–1416. https://doi.org/10.1101/gr.118042.110

14.

Rom

Heldt

N. A.

Gajghate

Seliga

Reichenbach

N. L.

Persidsky

(2020). Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles. Scientific Reports, 10(1), 7274. https://doi.org/10.1038/s41598-020-64349-x

15.

Umeda

Ikenouchi

Katahira-Tayama

Furuse

Sasaki

Nakayama

, et al. (2006). ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell, 126(4), 741–754. https://doi.org/10.1016/j.cell.2006.06.043

16.

Vaziri

N. D.

(2012). CKD Impairs barrier function and alters microbial flora of the intestine: A major link to inflammation and uremic toxicity. Current Opinion in Nephrology and Hypertension, 21(6), 587–592. https://doi.org/10.1097/MNH.0b013e328358c8d5

17.

Vaziri

N. D.

Wong

Pahl

Piceno

Y. M.

Yuan

DeSantis

T. Z.

, et al. (2013). Chronic kidney disease alters intestinal microbial flora. Kidney International, 83(2), 308–315. https://doi.org/10.1038/ki.2012.345

18.

Vaziri

N. D.

Zhao

Y. Y.

Pahl

M. V.

(2016). Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: The nature, mechanisms, consequences and potential treatment. Nephrology Dialysis Transplantation, 31(5), 737–746. https://doi.org/10.1093/ndt/gfv095

19.

Yang

H. L.

Thiyagarajan

Shen

P. C.

Mathew

D. C.

Lin

K. Y.

Liao

J. W.

, et al. (2019). Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis. Journal of Experimental & Clinical Cancer Research, 38(1), 186. https://doi.org/10.1186/s13046-019-1196-x

Study on the Intervention Mechanism of Guben Xiezhuo Recipe for Colon Dialysis on Urotoxin-Induced Intestinal Barrier Injury and Systemic Inflammation

Abstract

Background

Methods

Results

Conclusion

Keywords

Get full access to this article

References